Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder

PH94B has potential to be the First FDA-Approved PRN Treatment for Social Anxiety Disorder New Findings Presented at the 2019...

United BioSource LLC (UBC) goes live with its new version of UBC Pathways™ Electronic Benefits Verification (eBV) reaching more than 65% of covered lives in America.

BLUE BELL, Pa., March 29, 2019 /PRNewswire/ -- UBC, a global leader of late-stage and patient support services, has broadened its...

error: Content is protected !!